01/23/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/23/2020. The Emergency Committee convened by the World Health Organization (WHO) Director-General under the International Health Regulations (IHR) (2005) regarding the outbreak of novel coronavirus 2019 in the People’s Republic of China, with exportations currently reported in the Republic of Korea, Japan, Thailand, and Singapore, met on January 22-23, 2020. The advice was that the event did not constitute a Public Health Emergency of International Concern (PHEIC), but Committee members agreed on the urgency of the situation and suggested that the Committee should be reconvened in a matter of days to examine the situation further. This page provides the Committee's advice to WHO, affected countries, and the global community. (Text)
01/22/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 1/22/2020. This 12-page risk assessment is based on published information available as of January 21, 2020. On the basis of the information currently available, the European Centre for Disease Prevention and Control (ECDC) considers that the potential impact of 2019-nCoV outbreaks is high; further global spread is likely; there is currently a moderate likelihood of infection for European Union/European Economic Area (EU/EEA) travelers visiting Wuhan, China; and there is a moderate likelihood of detecting cases imported into EU/EEA countries. (PDF)
01/10/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 1/10/2020. The main aim of this five-page national capacities review tool is to better understand existing capacities in the area of detection and response to a novel coronavirus (nCoV) that is zoonotic and causes respiratory disease. The tool was developed with other coronaviruses, such as SARS-CoV and MERS-CoV, in mind and in consultation with member states. This information will help national authorities to identify main gaps, perform risk assessments, and plan for additional investigations, response, and control actions. (PDF)
01/01/2020 12:00 AM EST
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 1/2020. This Topic Collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange), updated in January 2020, highlights select laws, key issues, lessons learned, tools, and promising practices that can help healthcare professionals better understand the environment in which they will be asked to respond during large-scale emergencies. It will help healthcare professionals be aware of state and federal emergency management resources and support, as well as the authorities under which response operations may be conducted. (Text)
01/01/2020 12:00 AM EST
Source: CHS [Core Humanitarian Standard] Alliance. Published: 1/2020. This 24-page report presents the findings to date of the CHS Alliance-incubated Initiative to Cultivate Caring, Compassionate Aid Organisations. It considers well-being of humanitarian aid workers at the intersection between mental health, people management, and organizational culture. It proposes an inclusive, multi-stakeholder process as a way forward to address the findings, and summarizes findings and the vision for next steps. (PDF)
01/01/2020 12:00 AM EST
Source: Access to Medicine Foundation. Published: 1/2020. This 208-page report has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. It evaluates pharmaceutical companies in areas where they have the biggest potential and responsibility to limit antimicrobial resistance, such as R&D, managing manufacturing waste, and ensuring appropriate access and stewardship. (PDF)
06/01/2019 12:00 AM EDT
Source: Illinois Department of Public Health. Published: 6/2019. The purpose of this 99-page plan is to provide guidance and tools for all response partners involved in efforts to reduce the morbidity, mortality, and social disruption that would result from an outbreak of Ebola virus disease. It includes considerations for public health agencies, Emergency Medical Services (EMS), and healthcare systems. (PDF)
04/01/2019 12:00 AM EDT
Source: Centers for Disease Control and Prevention (CDC). Published: 4/2019. This competency-based course is the first in a three-part series on Public Health Emergency Law, and is designed for anyone engaging in public health emergency response planning and recovery. This unit covers Emergency Management Systems Preparedness and Response. (Video or Multimedia)
02/14/2019 12:00 AM EST
Source: Access to Medicine Foundation. Published: 2/14/2019. This 48-page document is the latest framework for tracking how pharmaceutical companies are responding to antimicrobial resistance (AMR), and sets out the methodology for the Antimicrobial Resistance Benchmark 2020. The AMR Benchmark 2020 measures 30 pharmaceutical companies, representing a cross-section of the pharmaceutical industry active in antibacterials and antifungals. (PDF)
01/23/2018 12:00 AM EST
Source: Access to Medicine Foundation. Published: 1/23/2018. This 185-page report is the first independent analysis of pharmaceutical company action against antimicrobial resistance, covering antimicrobial R&D, responsible manufacturing, and appropriate access and stewardship. It has evaluated 30 pharmaceutical companies, including those with the largest R&D divisions, the largest market presence, and specific expertise in developing critically needed medicines and vaccines. (PDF)
.png)
No hay comentarios:
Publicar un comentario